Genmab — April 2018
-
https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=a790b1d4-ad86-4988-ae00-445902efb689 Hvorfor kan en Ipad ikke læse disse meddelelser ?
-
Lidt opdateringer på " handelskrigen" Kina / USA http://nyheder.tv2.dk/udland/2018-04-04-ekspert-usa-og-kinas-toldkrig-kan-vaere-enormt-oedelaeggende
-
God morgen
-
God morgen.
-
Dommedagsprofetten Beskos er gået personligt konkurs, så hans hårde domme over Genmab og andre selskaber har tilsyneladende ikke holdt helt stik: http://borsen.dk/nyheder/avisen/artikel/11/195096/artikel.html#cxrecs_s
-
@concillado. Prøv at se link af hda 2/4 kl 23.32.
-
Ofatumumab is one of the drugs in this new trial : Hyper-CVAD in Combination With Inotuzumab Ozogamicin as Frontline Therapy for Adults With Acute Lymphocytic Leukemia -
https://clinicaltrials.gov/ct2/show/NCT03488225?term=NCT03488225&rank=1 -
Ree var en dygtig investor i 2017 med Genmab i porteføljen https://finans.dk/erhverv/ECE10479555/karsten-ree-var-taet-paa-milliardafkast-i-2017/?ctxref=forside
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind